Wildevuur CR - Search Results

1

Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass.

van Oeveren W, Jansen NJ, Bidstrup BP, Royston D, Westaby S, Neuhof H, Wildevuur CR. van Oeveren W, et al. Among authors: wildevuur cr. Ann Thorac Surg. 1987 Dec;44(6):640-5. doi: 10.1016/s0003-4975(10)62153-4. Ann Thorac Surg. 1987. PMID: 2446574 Clinical Trial.

2

Bubble oxygenation and cardiotomy suction impair the host defense during cardiopulmonary bypass: a study in dogs.

van Oeveren W, Dankert J, Wildevuur CR. van Oeveren W, et al. Among authors: wildevuur cr. Ann Thorac Surg. 1987 Nov;44(5):523-8. doi: 10.1016/s0003-4975(10)62114-5. Ann Thorac Surg. 1987. PMID: 3675057

3

Blood activation during neonatal extracorporeal life support.

Plötz FB, van Oeveren W, Bartlett RH, Wildevuur CR. Plötz FB, et al. Among authors: wildevuur cr. J Thorac Cardiovasc Surg. 1993 May;105(5):823-32. J Thorac Cardiovasc Surg. 1993. PMID: 7683735

4

Preoperative therapy of low-dose aspirin in internal mammary artery bypass operations with and without low-dose aprotinin.

Schönberger JP, Bredée JJ, van Oeveren W, van Zundert AA, Verkroost M, Terwoorst J, Bavinck JH, Berreklouw E, Wildevuur CR. Schönberger JP, et al. Among authors: wildevuur cr. J Thorac Cardiovasc Surg. 1993 Aug;106(2):262-7. J Thorac Cardiovasc Surg. 1993. PMID: 7688059

5

Systemic blood activation during and after autotransfusion.

Schönberger JP, van Oeveren W, Bredée JJ, Everts PA, de Haan J, Wildevuur CR. Schönberger JP, et al. Among authors: wildevuur cr. Ann Thorac Surg. 1994 May;57(5):1256-62. doi: 10.1016/0003-4975(94)91369-2. Ann Thorac Surg. 1994. PMID: 8179396 Clinical Trial.

6

Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass.

Gu YJ, van Oeveren W, Akkerman C, Boonstra PW, Huyzen RJ, Wildevuur CR. Gu YJ, et al. Among authors: wildevuur cr. Ann Thorac Surg. 1993 Apr;55(4):917-22. doi: 10.1016/0003-4975(93)90117-z. Ann Thorac Surg. 1993. PMID: 8466349 Clinical Trial.

7

Platelet preservation during cardiopulmonary bypass with aprotinin.

Wildevuur CR, Eijsman L, Roozendaal KJ, Harder MP, Chang M, van Oeveren W. Wildevuur CR, et al. Eur J Cardiothorac Surg. 1989;3(6):533-7; discussion 537-8. doi: 10.1016/1010-7940(89)90114-0. Eur J Cardiothorac Surg. 1989. PMID: 2483979 Clinical Trial.

8

Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass.

Jansen NJ, van Oeveren W, Gu YJ, van Vliet MH, Eijsman L, Wildevuur CR. Jansen NJ, et al. Among authors: wildevuur cr. Ann Thorac Surg. 1992 Oct;54(4):744-7; discussion 747-8. doi: 10.1016/0003-4975(92)91021-z. Ann Thorac Surg. 1992. PMID: 1417233

9

Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass.

Jansen NJ, van Oeveren W, van den Broek L, Oudemans-van Straaten HM, Stoutenbeek CP, Joen MC, Roozendaal KJ, Eysman L, Wildevuur CR. Jansen NJ, et al. Among authors: wildevuur cr. J Thorac Cardiovasc Surg. 1991 Oct;102(4):515-25. J Thorac Cardiovasc Surg. 1991. PMID: 1656149 Clinical Trial.

10

Aprotinin protects platelets against the initial effect of cardiopulmonary bypass.

van Oeveren W, Harder MP, Roozendaal KJ, Eijsman L, Wildevuur CR. van Oeveren W, et al. Among authors: wildevuur cr. J Thorac Cardiovasc Surg. 1990 May;99(5):788-96; discussion 796-7. J Thorac Cardiovasc Surg. 1990. PMID: 1691806 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208 results

Search Page

Filters